Published in Stroke on December 01, 1990
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A (2001) 2.16
Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci (2012) 1.89
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J (2006) 1.55
Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol (1994) 1.13
Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br J Clin Pharmacol (1992) 1.01
Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors. Br J Pharmacol (2010) 0.99
A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain. Br J Pharmacol (2001) 0.97
The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br J Pharmacol (1991) 0.90
Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids. J Neurol Neurosurg Psychiatry (2002) 0.88
CSF and Serum Biomarkers Focusing on Cerebral Vasospasm and Ischemia after Subarachnoid Hemorrhage. Stroke Res Treat (2013) 0.85
Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity. Br J Pharmacol (2010) 0.84
Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. Inflammopharmacology (2011) 0.83
Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor. Br J Pharmacol (1993) 0.80
Temperature dependence of synaptic responses in guinea pig hippocampal CA1 neurons in vitro. Cell Mol Neurobiol (2002) 0.80
The application of permanent middle cerebral artery ligation in the mouse. J Vis Exp (2011) 0.78
Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration. Br J Pharmacol (1993) 0.77
Neuroprotective Mechanisms of Taurine against Ischemic Stroke. Brain Sci (2013) 0.76
Ischemia induces release of endogenous amino acids from the cerebral cortex and cerebellum of developing and adult mice. J Amino Acids (2013) 0.75
Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult. PLoS One (2015) 0.75
Diffuse axonal injury and traumatic coma in the primate. Ann Neurol (1982) 4.08
Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol (1982) 3.82
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med (1995) 3.77
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth (2001) 3.47
Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology (1989) 3.24
Patients with head injury who talk and die. Lancet (1975) 3.20
Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 3.18
Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. J Neurosurg (1999) 3.12
Diffuse brain damage of immediate impact type. Its relationship to 'primary brain-stem damage' in head injury. Brain (1977) 2.96
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91
A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease. Int J Clin Pract (2002) 2.86
Costs and use of mental health services before and after managed care. Health Aff (Millwood) (1998) 2.77
Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol (1998) 2.73
Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology (2005) 2.58
Neocortical death after cardiac arrest. A clinical, neurophysiological, and neuropathological report of two cases. Lancet (1971) 2.52
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett (1993) 2.35
Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci (1999) 2.32
Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry (1999) 2.25
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg (1996) 2.07
Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg (1993) 2.06
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ (1994) 1.83
Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem (1997) 1.76
Ischaemic brain damage in fatal non-missile head injuries. J Neurol Sci (1978) 1.74
Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience (2005) 1.71
Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology (2009) 1.70
Ischaemic brain damage in fatal head injuries. Lancet (1971) 1.69
The neuropathology of the vegetative state after an acute brain insult. Brain (2000) 1.67
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma (1997) 1.64
Brain damage in fatal non-missile head injury. J Clin Pathol (1980) 1.58
High level of extracellular potassium and its correlates after severe head injury: relationship to high intracranial pressure. J Neurosurg (2000) 1.54
Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival. Stroke (2000) 1.51
The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol (1988) 1.49
The contusion index: a reappraisal in human and experimental non-missile head injury. Neuropathol Appl Neurobiol (1985) 1.49
Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int (2004) 1.48
Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension. Br Med J (1975) 1.46
Apoptosis after traumatic brain injury. J Neurotrauma (2000) 1.45
Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP. Cephalalgia (1995) 1.44
Head injury in man and experimental animals: neuropathology. Acta Neurochir Suppl (Wien) (1983) 1.42
Alveolar and plasma concentrations of interleukin-8 and vascular endothelial growth factor following oesophagectomy. Anaesthesia (2004) 1.42
Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med (2001) 1.41
Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest (1996) 1.38
Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J Neurosci (1996) 1.37
Effects of large doses of colistin sulphomethate sodium on renal function. Br Med J (1970) 1.37
Internalization of neuronal plasma membrane ricin receptors into the Golgi apparatus. Exp Cell Res (1975) 1.36
Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res (1976) 1.35
The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol (1998) 1.32
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett (1994) 1.32
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Diffuse axonal injury in head injuries caused by a fall. Lancet (1984) 1.29
Diffuse axonal injury in non-missile head injury. J Neurol Neurosurg Psychiatry (1991) 1.28
Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry (1987) 1.27
Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab (1987) 1.26
Traumatic axonal injury: practical issues for diagnosis in medicolegal cases. Neuropathol Appl Neurobiol (2000) 1.26
Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry (1997) 1.24
Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke (2001) 1.24
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Amyloid beta-protein, APOE genotype and head injury. Ann N Y Acad Sci (1996) 1.21
The neuropathology of the vegetative state after head injury. J Clin Pathol (1999) 1.21
Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg (1999) 1.21
Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol (1999) 1.21
Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab (1993) 1.18
The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol (2013) 1.18
The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev (2006) 1.17
Aging-associated changes in human brain. J Neuropathol Exp Neurol (1997) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol (1995) 1.17
Cerebral circulation and norepinephrine: relevance of the blood-brain barrier. Am J Physiol (1976) 1.16
Brain damage in non-missile head injury secondary to high intracranial pressure. Neuropathol Appl Neurobiol (1987) 1.15
Axonal injury in the optic nerve: a model simulating diffuse axonal injury in the brain. J Neurosurg (1989) 1.15
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Correlation between angiographic findings and the ischaemia of head injury. J Neurol Neurosurg Psychiatry (1978) 1.15
Effects of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow and pial arteriolar caliber. Stroke (1980) 1.13
Effects of dexamethasone and betamethasone on in vitro cultures from human astrocytoma. Br J Cancer (1977) 1.12
Intracranial haemorrhage induced at arterial pressure in the rat. Part 2: Short term changes in local cerebral blood flow measured by autoradiography. Neurol Res (1984) 1.12
Loss of axonal microtubules and neurofilaments after stretch-injury to guinea pig optic nerve fibers. J Neurotrauma (1997) 1.12
Changes in the hippocampus and the cerebellum resulting from hypoxic insults: frequency and distribution. Acta Neuropathol (1989) 1.11
Tau immunohistochemistry in acute brain injury. Neuropathol Appl Neurobiol (2003) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet (2001) 1.08
Deep intracerebral (basal ganglia) haematomas in fatal non-missile head injury in man. J Neurol Neurosurg Psychiatry (1986) 1.08
Is beta-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol (1996) 1.08
Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 1.07
The hemodynamic effects of internal carotid artery stenosis and occlusion. J Neurosurg (1987) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
Craniocerebral trauma: protection and retrieval of the neuronal population after injury. Neurosurgery (1998) 1.06
There is differential loss of pyramidal cells from the human hippocampus with survival after blunt head injury. J Neuropathol Exp Neurol (2003) 1.06
Correction of neuromuscular scoliosis in patients with preexisting respiratory failure. Spine (Phila Pa 1976) (2006) 1.06